Preferred Label : cerliponase alfa;

Registry Number MeSH : EC 3.4.14.-;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://ansm.sante.fr/tableau-marr/cerliponase-alfa
2025
false
false
false
France
French
guidelines for drug use
risk management
cerliponase alfa
cerliponase alfa
infusions, intracerebroventricular
Movement of device from original site
Device related infection
Device occlusion
infusions, intracerebroventricular

---
https://www.has-sante.fr/jcms/p_3571320/fr/brineura-cerliponase-alfa-maladie-rare
2024
false
false
false
France
evaluation of the transparency committee
cerliponase alfa
cerliponase alfa
disease, nos
Brineura
rare diseases

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00430
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
cerliponase alfa
cerliponase alfa
cerliponase alfa
enzyme replacement therapy
ceroid lipofuscinosis, neuronal, 2
child
adult
infusions, intraventricular
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
recombinant proteins
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
recombinant proteins
neuronal ceroid-lipofuscinoses

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.